drugset / Trial / NCT02195375
Flutiform® Compared With Seretide® in the Treatment of COPD
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to investigate whether flutiform® is effective and safe in the treatment of chronic obstructive pulmonary disease (COPD).
Timeline
- Start
- 2014-09
- Primary completion
- 2016-05
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone | Other / unclassified | 250 ug | — |
| Subject | Fluticasone | Other / unclassified | 500 ug | — |
| Subject | Formoterol | Other / unclassified | 10 ug | — |
| Subject | Formoterol | Other / unclassified | 20 ug | — |
| Comparator | Salmeterol | Other / unclassified | 50 ug | — |